XYLOCAINE JELLY 2%

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

LIGNOCAINE HCl

Available from:

DCH AURIGA SINGAPORE

ATC code:

N01BB02

Dosage:

20 mg/g

Pharmaceutical form:

GEL

Composition:

LIGNOCAINE HCl 20 mg/g

Administration route:

TOPICAL

Prescription type:

General Sale List

Manufactured by:

Recipharm Karlskoga AB

Authorization status:

ACTIVE

Authorization date:

1991-04-08

Patient Information leaflet

05/AC/SG/PAIN.000-078-338.6.0
Xylocaine Jelly 2%
_lidocaine hydrochloride _
Jelly
Composition
_Active constituent: _
Pharmaceutical form
Xylocaine jelly is a clear to almost clear, slightly coloured
jelly. The vehicle of the active ingredient consists of water
thickened with hydroxypropyl methylcellulose. Jelly syringes
are free from preservatives. Jelly in tubes contains methyl
parahydroxybensoate and propyl parahydroxybensoate.
Indications
Xylocaine jelly is indicated as a surface anaesthetic and
lubricant for:
-
The male and female urethra during cystoscopy,
catheterisation, exploration by sound and other
endourethral procedures.
-
Nasal and pharyngeal cavities in endoscopic procedures
such as gastroscopy and bronchoscopy.
-
During proctoscopy and rectoscopy.
-
Tracheal intubation.
-
Symptomatic treatment of pain in connection with cystitis
and urethritis.
Dosage and method of administration
Xylocaine jelly 2% provides prompt and profound anaesthesia
of mucous membranes, giving effective anaesthesia of long
As with any local anaesthetic, the safety and effectiveness of
lidocaine depend on the proper dosage, the correct technique,
adequate precautions and readiness for emergencies.
The following dosage recommendations should be regarded
as a guide. The clinician’s experience and knowledge of the
patient’s physical status are of importance in calculating the
required dose.
Absorption from mucous membranes is variable but
especially high from the bronchial tree. The absorption of
lidocaine jelly from the nasopharynx is usually lower than with
other lidocaine products. Blood concentrations of lidocaine
after instillation of the jelly in the intact urethra and bladder in
doses up to 800 mg are fairly low and below toxic levels.
Debilitated or elderly patients, children over 12 years of age,
acutely ill patients or patients with sepsis should be given
doses commensurate with their age, weight and physical
condition.
In children under the age of 12 years the dose should not
exceed 4 mg/kg.
Urethral anaesthesia
Su

Summary of Product characteristics

05/AC/SG/PAIN.000-078-338.6.0
Xylocaine Jelly 2%
_lidocaine hydrochloride _
Jelly
Composition
_Active constituent: _
Pharmaceutical form
Xylocaine jelly is a clear to almost clear, slightly coloured
jelly. The vehicle of the active ingredient consists of water
thickened with hydroxypropyl methylcellulose. Jelly syringes
are free from preservatives. Jelly in tubes contains methyl
parahydroxybensoate and propyl parahydroxybensoate.
Indications
Xylocaine jelly is indicated as a surface anaesthetic and
lubricant for:
-
The male and female urethra during cystoscopy,
catheterisation, exploration by sound and other
endourethral procedures.
-
Nasal and pharyngeal cavities in endoscopic procedures
such as gastroscopy and bronchoscopy.
-
During proctoscopy and rectoscopy.
-
Tracheal intubation.
-
Symptomatic treatment of pain in connection with cystitis
and urethritis.
Dosage and method of administration
Xylocaine jelly 2% provides prompt and profound anaesthesia
of mucous membranes, giving effective anaesthesia of long
As with any local anaesthetic, the safety and effectiveness of
lidocaine depend on the proper dosage, the correct technique,
adequate precautions and readiness for emergencies.
The following dosage recommendations should be regarded
as a guide. The clinician’s experience and knowledge of the
patient’s physical status are of importance in calculating the
required dose.
Absorption from mucous membranes is variable but
especially high from the bronchial tree. The absorption of
lidocaine jelly from the nasopharynx is usually lower than with
other lidocaine products. Blood concentrations of lidocaine
after instillation of the jelly in the intact urethra and bladder in
doses up to 800 mg are fairly low and below toxic levels.
Debilitated or elderly patients, children over 12 years of age,
acutely ill patients or patients with sepsis should be given
doses commensurate with their age, weight and physical
condition.
In children under the age of 12 years the dose should not
exceed 4 mg/kg.
Urethral anaesthesia
Su